Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial

Sjoerd H. Hofma1*, MD, PhD; Pieter C. Smits2, MD, PhD; Jan Brouwer1, MD, PhD; Matthijs A. Velders1, MD, PhD; Arnoud W.J. van ’t Hof3, MD, PhD; Michel Queré1, MD; Cornelis Jan de Vries1, MD; Adrianus J. van Boven1, MD, PhD